Published in Gene Therapy Weekly, June 13th, 2002
The most significant event that influenced the company's operations during 2001 was the launching of its proprietary ACE System, a chromosome-based vehicle for carrying genes into cells for subsequent expression of proteins.
"Development of The ACE System is pivotal to executing a focused business strategy for 2002," said Alistair Duncan, president and CEO of Chromos. We are now able to build on this milestone achievement by marketing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.